Percheron Therapeutics Ltd (ASX:PER – Get Free Report) insider James Garner bought 375,000 shares of the stock in a transaction dated Thursday, November 14th. The shares were acquired at an average price of A$0.08 ($0.05) per share, for a total transaction of A$30,000.00 ($19,480.52).
Percheron Therapeutics Stock Performance
Percheron Therapeutics Company Profile
Pernod Ricard SA produces and sells wines and spirits worldwide. It offers its products under various brands. The company was founded in 1805 and is headquartered in Paris, France.
See Also
- Five stocks we like better than Percheron Therapeutics
- How to Choose Top Rated Stocks
- Target Results Are Not a Retail Bellwether: Why the Dip Is a Buy
- What is a Death Cross in Stocks?
- Williams-Sonoma Stock: Buy It and Never Let It Go
- 3 Stocks to Consider Buying in October
- 5 Dividend ETFs to Buy and Hold Forever
Receive News & Ratings for Percheron Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Percheron Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
